The store will not work correctly when cookies are disabled.
N-(4-amino-3-(trifluoromethyl)phenyl)-4-methylbenzenesulfonamide
ID: ALA4744629
PubChem CID: 16777240
Max Phase: Preclinical
Molecular Formula: C14H13F3N2O2S
Molecular Weight: 330.33
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccc(S(=O)(=O)Nc2ccc(N)c(C(F)(F)F)c2)cc1
Standard InChI: InChI=1S/C14H13F3N2O2S/c1-9-2-5-11(6-3-9)22(20,21)19-10-4-7-13(18)12(8-10)14(15,16)17/h2-8,19H,18H2,1H3
Standard InChI Key: YWTBWBHMWBIXEQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 23 0 0 0 0 0 0 0 0999 V2000
24.4992 -10.1860 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.0948 -9.4802 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
23.6858 -10.1834 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.5131 -9.4802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5120 -10.2997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2200 -10.7087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9297 -10.2993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9268 -9.4766 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2182 -9.0713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8053 -9.0718 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.3899 -9.0721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3933 -8.2543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6864 -7.8460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9778 -8.2548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9806 -9.0762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6881 -9.4809 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6380 -10.7068 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.2198 -11.5259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5120 -11.9343 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
26.9274 -11.9347 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
26.2120 -12.3404 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
21.2694 -7.8473 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
4 10 1 0
10 2 1 0
2 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
7 17 1 0
6 18 1 0
18 19 1 0
18 20 1 0
18 21 1 0
14 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 330.33 | Molecular Weight (Monoisotopic): 330.0650 | AlogP: 3.40 | #Rotatable Bonds: 3 |
Polar Surface Area: 72.19 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.44 | CX Basic pKa: 2.35 | CX LogP: 3.02 | CX LogD: 2.99 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.85 | Np Likeness Score: -1.69 |
References
1. Xu F,Zhao Y,Zhou H,Li C,Zhang X,Hou T,Qu L,Wei L,Wang J,Liu Y,Liang X. (2020) Synthesis and evaluation of 3-(4-(phenoxymethyl)phenyl)propanoic acid and N-phenylbenzenesulfonamide derivatives as FFA4 agonists., 30 (24): [PMID:33127539] [10.1016/j.bmcl.2020.127650] |